Cambrex Acquires Avista Pharma Solutions

Avista Healthcare Partners Acquires Trillium Health Care Products

August 7, 2024

Pharmaceuticals

Avista Healthcare Partners has completed the acquisition of Trillium Health Care Products, a Brockville, Ontario-based CDMO specializing in branded over‑the‑counter (OTC) products, from New Water Capital. Avista plans to invest in Trillium’s growth, expand its footprint and capabilities, and use the business as a consumer‑healthcare platform for potential strategic add‑on acquisitions.

ADQ Acquires Acino from Avista Capital and Nordic Capital

September 16, 2021

Pharmaceuticals

Abu Dhabi holding company ADQ has agreed to acquire Acino, a Swiss pharmaceutical company headquartered in Zurich, from private equity owners Avista Capital Partners and Nordic Capital. The transaction supports ADQ's strategy to build a regional pharmaceuticals and healthcare platform, expanding capabilities in manufacturing, commercialization and distribution across emerging markets.

Belcan Acquires AVISTA

November 18, 2020

Aerospace & Defense

Belcan, a portfolio company of AE Industrial Partners, acquired AVISTA, Inc., a provider of safety-critical and mission-critical software engineering services, from TransDigm Group. The acquisition adds systems and software engineering capability to Belcan's offering and expands its Midwest footprint with AVISTA's locations in Platteville, Cedar Rapids and Blaine; AVISTA's management team will join Belcan.

Noramco Acquires Cambrex Drug Product Business Unit (Halo Pharmaceuticals)

November 2, 2023

Pharmaceuticals

Noramco has completed the acquisition of the Cambrex Drug Product Business Unit (previously Halo Pharmaceuticals), adding drug product formulation development, clinical and commercial manufacturing, and packaging capabilities from sites in Mirabel, Québec and Whippany, New Jersey. The purchase expands Noramco's service offering beyond APIs, brings nearly 400 employees into the Noramco group, and represents Cambrex's strategic divestiture to focus on its drug substance and analytical testing businesses.

Avista Capital Partners Acquires Solmetex, LLC

December 17, 2020

Medical Devices

Avista Capital Partners, a New York-based private equity firm focused on healthcare, has completed its acquisition of Solmetex, the leading provider of amalgam separators and dental waste-compliance products and services. The deal (terms undisclosed) transfers ownership from prior investors including AVALT and Gemini Investors (and referenced Riveria Investment Group), with Avista planning to invest in product development and accelerate domestic and international expansion.

Avista Capital Partners Invests in eMolecules

March 25, 2021

Healthcare Services

Avista Capital Partners has signed a definitive agreement to invest in eMolecules, a San Diego–based e-procurement and marketplace platform for high-value chemicals and bioreagents used in drug discovery. Financial terms were not disclosed; Avista said the investment will support eMolecules' growth and expansion into additional biopharma and academic customers.